Learn More: What is Breast Cancer? An OverviewSurgery and RadiationSurgery is the most common treatment for breast cancer, and there are several types:Breast-sparing (or breast-conserving) surgery removes the cancer but not the breast. Examples are lumpectomy and segmental (partial) mastectomy. ...
Breast cancer treatment pathway improvement using time‐driven activity‐based costingactivity‐based costing (ABC)costs of careleanperformance improvementtime‐driven activity‐based costing (TDABC)Summary Time‐driven activity‐based costing (TDABC) is increasingly used to establish more accurate and time...
Provides an international platform for the discussion and resolution of ongoing controversies in breast cancer treatment. For over 35 years, it has served as a reliable resource for a wide audience of researchers and professionals. With 800K+ article downloads each year, it offers a high visibilit...
The high incidence of breast cancer is the greastest threat to women’ health all over the world. Among them, HER-2 positive breast cancer has the characteristics of high malignancy, easy recurrence and metastasis, and poor prognosis. Traditional Chinese
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer Author links open overlay panelAli Masjedi a b c, Vida Hashemi d, Mohammad Hojjat-Farsangi e f, Ghasem Ghalamfarsa g, Gholamreza Azizi h, Mehdi Yousefi a b, Farhad ...
Typically, women in South Africa (SA) are diagnosed with breast cancer when they self-present with symptoms to health facilities. The aim of this study was to determine the pathway that women follow to breast cancer care and factors associated with this journey. A cross-sectional study was con...
Does lapatinib, a small-molecule tyrosine kinase inhibitor, constitute a breakthrough in the treatment of breast cancer? ErbB/HER receptor or its signal transduction pathway is an attractive therapeutic target for breast cancer. Lapatinib, an orally administered dual inhibito... Yoshinori,Ito,Nahomi,...
The resistance to endocrine therapy might be related to the activation of the PI3K/AKT/mTOR signaling pathway. The phase III randomized controlled clinical trial BOLERO-2 has confirmed that, for ABC patients who progressed upon non-steroidal AI treatment, mTOR inhibitor everolimus combined with exemes...
Several additional genes associated with breast cancer risk are part of the BRCA network and there is a clear relationship with the Fanconi pathway [9]. Genes in this network point to reduced HR-DNA repair as the mechanism underlying cancer susceptibility, although the precise functions of ...
Dr. Sandeep Nayak is one of the best when it comes to cancer treatment in Bangalore. His main expertise as an onco-surgeon is “robotic & laparoscopic” cancer surgery